Ilika: Pioneering Solid-State Battery Advancements (LON:IKA)
27 January 2025
Medpace Holdings, Inc. (NASDAQ: MEDP) stands out in the competitive landscape of the healthcare sector, particularly within the diagnostics and research industry. With a market capitalization of $17.27 billion, Medpace..
BrightSpring Health Services, Inc. (BTSG) has emerged as a noteworthy player in the healthcare sector, offering a robust investment opportunity for those interested in health information services. With its market..
TG Therapeutics, Inc. (NASDAQ: TGTX) is garnering attention in the biotechnology sector, not least due to its impressive market cap of $8.79 billion and a promising potential upside of 21.39%...
Grifols, S.A. (NASDAQ: GRFS), a prominent player in the healthcare sector specializing in the production and marketing of plasma-derived medicines, presents an intriguing opportunity for investors with a potential upside..
Inspire Medical Systems, Inc. (NASDAQ: INSP) is a noteworthy player in the healthcare sector, specifically within the medical devices industry. The company has carved out a niche by developing and..
Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a key player in the biotechnology sector, is capturing investor attention with its promising pipeline for treating rare genetic disorders. Headquartered in Cambridge, Massachusetts, this..
Doximity, Inc. (NASDAQ: DOCS), a leading player in the health information services industry, has caught the attention of investors with its promising 13.64% potential upside. With a market capitalization of..
Ascendis Pharma A/S (NASDAQ: ASND), a biopharmaceutical innovator based in Hellerup, Denmark, has captured investor attention with its impressive 37.21% potential upside. Specializing in TransCon-based therapies, the company addresses unmet..
RadNet, Inc. (NASDAQ: RDNT), a prominent player in the healthcare sector, is capturing significant attention from investors with its compelling growth prospects and technological innovations in the diagnostics and research..
Incyte Corporation (INCY), a prominent player in the biotechnology sector, is capturing investor attention with its impressive revenue growth and a robust pipeline of innovative therapeutics. Headquartered in Wilmington, Delaware,..
Investors seeking opportunities in the healthcare sector might find HealthEquity, Inc. (NASDAQ: HQY) an intriguing option, given its robust market position and promising growth potential. With a market cap of..
Alkermes plc (NASDAQ: ALKS) is a prominent player in the healthcare sector, specifically in the specialty and generic drug manufacturing industry. With its headquarters in Dublin, Ireland, the company has..
TransMedics Group, Inc. (NASDAQ: TMDX) is a pioneering force in the healthcare sector, specifically within the medical devices industry. Renowned for its groundbreaking Organ Care System (OCS), the company seeks..
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is making waves in the biotechnology sector, particularly with its innovative focus on treating rare neuroendocrine diseases. With a market capitalization of $6.77 billion, Rhythm..
Encompass Health Corporation (NYSE: EHC), a key player in the healthcare sector, stands out in the medical care facilities industry with a market capitalization of $12.18 billion. Headquartered in Birmingham,..
Mettler-Toledo International Inc. (NYSE: MTD) stands as a formidable player in the diagnostics and research industry, with a market capitalization of $30.29 billion. Renowned for its precision instruments and services,..
Quest Diagnostics Incorporated (NYSE: DGX) stands as a formidable entity in the healthcare sector, specializing in diagnostics and research. With a market capitalization of $26.08 billion, this industry leader offers..
iRhythm Holdings, Inc. (NASDAQ: IRTC) is a compelling player in the healthcare sector, specifically within the medical devices industry. With a market cap of $3.64 billion, the San Francisco-based digital..
Atrium Therapeutics, Inc. (NASDAQ: RNA) is making waves in the biotechnology sector with its pioneering approach to RNA therapeutics aimed at combating cardiomyopathies. Headquartered in San Diego, this innovative biopharmaceutical..
Halozyme Therapeutics, Inc. (NASDAQ: HALO) stands out in the biotechnology sector with its impressive market cap of $12.93 billion, reflecting a strong presence in the healthcare industry. Founded in 1998..
